Loading...
01/11 13:58
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlighted strong financial performance with revenue and ARR growth, a positive adjusted EBITDA, and improved cash flow. The Q&A revealed a balanced strategy with a shift towards subscriptions, strong market interest, and efficient inventory management. Although there were some uncertainties in management responses, the overall sentiment is positive, supported by strategic growth in diverse markets and a new certified pre-owned program. The stock price is likely to react positively over the next two weeks, driven by these factors.
Revenue $32.5 million, up 2% sequentially and 29% year-over-year. This reflects strong new customer growth as well as expanding deployments in our installed base.
Annual Recurring Revenue (ARR) $110.5 million, reflecting growth of 27% year-over-year. This growth is attributed to strong customer retention and expansion.
Adjusted EBITDA Positive $2 million in Q2 2025 compared to a loss of $8 million in the second quarter of last year. Adjusted EBITDA margin was 6% in Q2 2025. This improvement reflects cost structure reductions and improved corporate efficiency.
Cash, Cash Equivalents, and Marketable Securities $37 million, up $2 million sequentially from $35 million at the end of Q1. This increase reflects tighter inventory management, stronger collection activity, and insurance reimbursements.
Adjusted Gross Margin 55% in Q2 2025 compared to 59% in the same period last year. This includes a noncash $1.8 million inventory reserve related to Express Gen1 parts. Excluding these reserve charges, adjusted gross margin would have been approximately 60%.
Adjusted Operating Expenses $21.6 million compared to $26.7 million in the second quarter of last year, a 19% year-over-year decline. This reflects actions taken to reduce spend and improve efficiency.
Cash Flow from Operations $2.1 million in Q2 2025, improving significantly from the $21.6 million used in the same quarter last year. This improvement is attributed to tighter inventory management and stronger collection activity.
Remaining Performance Obligation (RPO) Approximately $275 million as of June 30, 2025, compared to approximately $261 million as of March 31, 2025. This reflects the remaining contracted value of long-term subscriptions.
eXpedite: The autonomous AI-based bag screening solution has gained momentum since its launch in Q4 '24. In Q2 '25, 8 new customers were added, bringing the total to 20 customers. Demand is strong, including a recent order for over 100 systems.
Gen2 Express platform: Customers are upgrading to this platform, often before their Gen1 contracts expire. These upgrades include new 4-year commitments, increasing customer stickiness and expanding RPO.
Education: Expanded presence in 20 new school districts across the U.S. in Q2 '25. Secured a $15 million contract with Gwinnett County Public Schools, Georgia's largest school district.
Healthcare: Secured contracts with Ohio State University Wexner Medical Center, Virginia Mason Franciscan Health, and Broward Health, reflecting growing demand for security solutions in hospitals.
Sports and Entertainment: New wins include Inter Miami CF, FC Cincinnati, and NBA training facilities. Renewals and upgrades with long-standing customers like Nissan Stadium and Gillette Stadium.
Industrial Workplace: Secured a significant win with a Fortune 50 company deploying technology across high-traffic industrial distribution facilities and corporate headquarters.
Cost Structure and Efficiency: Reduced cost structure and improved corporate efficiency over the last 9 months. Achieved a sequential increase in liquidity for the first time, with cash and equivalents rising to $37 million.
Subscription Model Shift: Shifted purchase activity back to direct fulfillment, offering higher revenue, lifetime value, and ARR compared to distribution fulfillment.
Leadership Transition: Mike Ellenbogen, a key leader, is stepping down as an active employee but will remain a trusted adviser and board member.
Legal Resolutions: The company is no longer under DOJ investigation and has reached a settlement in a securities class action lawsuit, with direct financial exposure limited to $1 million.
DOJ Investigation: The company was previously under investigation by the U.S. Department of Justice, which could have posed significant legal and reputational risks. Although the investigation has concluded, it highlights potential vulnerabilities in compliance and governance.
Securities Class Action Lawsuit: The company is involved in a securities class action lawsuit, which, while largely covered by insurance, still exposes the company to a $1 million financial liability and potential reputational damage.
Cost Structure and Efficiency: The company has been working to stabilize its cost structure and improve operational efficiency, indicating prior inefficiencies that could have impacted financial performance.
Shift in Sales Model: The transition to a direct purchase subscription model from a distribution subscription model introduces short-term gross margin headwinds, which could impact profitability in the near term.
Education Market Deployment: Large education contracts involve high volumes of a newer product, eXpedite, which has not yet achieved full cost efficiency, potentially affecting margins.
Inventory Reserves: A $1.8 million non-cash inventory reserve related to Gen1 parts indicates challenges in inventory management and potential obsolescence issues.
Credit Facility: The company secured a $75 million credit facility, which, while providing financial flexibility, adds $250,000 in monthly interest expenses, increasing financial obligations.
Revenue Growth: The company expects total revenue to grow by 27% to 30% in 2025, reaching between $132 million and $135 million. This is an increase from the prior guidance of $125 million to $130 million.
Adjusted Gross Margin: Adjusted gross margin is expected to be in the range of 54% to 56% for the remainder of the year, reflecting a shift to in-house purchase fulfillment and the timing of large education contracts involving high volumes of eXpedite.
Adjusted EBITDA: The company expects to deliver positive full-year adjusted EBITDA in 2025, with adjusted EBITDA margins in the mid-single digits, an improvement from the previous guidance of low to mid-single digits.
Cash Flow: The company remains on track to be cash flow positive in the fourth quarter of 2025.
ARR Growth: Annual recurring revenue (ARR) was $110.5 million as of June 30, 2025, reflecting 27% year-over-year growth. The company expects ARR to continue growing, driven by subscription-based sales models and customer upgrades to Gen2.
Education Market Expansion: The company secured a $15 million contract with Gwinnett County Public Schools and expects larger education market transactions in Q3, which will drive upfront revenue and ARR growth.
Product Adoption: The eXpedite product is gaining momentum, with 20 customers since its launch in Q4 2024. The company expects broader adoption and enhanced subscription model stickiness.
Market Trends: The company sees growing demand in education, healthcare, sports, and entertainment markets, with significant wins and expansions in these sectors.
The selected topic was not discussed during the call.
The earnings call highlights strong financial performance with a 57% increase in revenue and positive adjusted EBITDA. Despite a decline in gross margin due to strategic shifts, the company has secured a significant contract and shows robust ARR growth. The Q&A session reveals positive sentiment towards strategic changes and future growth in various verticals. The partnership with Plexus and the education market expansion further support a positive outlook. However, some uncertainties remain regarding the pipeline of large contracts. Overall, the company is well-positioned for growth, suggesting a positive stock price movement.
The earnings call highlighted strong financial performance with revenue and ARR growth, a positive adjusted EBITDA, and improved cash flow. The Q&A revealed a balanced strategy with a shift towards subscriptions, strong market interest, and efficient inventory management. Although there were some uncertainties in management responses, the overall sentiment is positive, supported by strategic growth in diverse markets and a new certified pre-owned program. The stock price is likely to react positively over the next two weeks, driven by these factors.
The earnings call reveals strong financial performance with significant revenue growth (44% YoY) and positive EBITDA, indicating improved operational efficiency. Despite cash flow concerns due to one-time costs, the company's focus on subscription growth and strategic expansion in promising verticals like healthcare and sports is promising. The Q&A session highlighted optimism about new legislation driving demand and a robust subscription model. While no shareholder returns were announced, the overall outlook and strategic focus suggest a positive sentiment, likely resulting in a 2% to 8% stock price increase.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
